IL-1beta, IL-6, and RANTES as biomarkers of Chikungunya severity.

<h4>Background</h4>Little is known about the immunopathogenesis of Chikungunya virus. Circulating levels of immune mediators and growth factors were analyzed from patients infected during the first Singaporean Chikungunya fever outbreak in early 2008 to establish biomarkers associated wi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lisa F P Ng, Angela Chow, Yong-Jiang Sun, Dyan J C Kwek, Poh-Lian Lim, Frederico Dimatatac, Lee-Ching Ng, Eng-Eong Ooi, Khar-Heng Choo, Zhisheng Her, Philippe Kourilsky, Yee-Sin Leo
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2009
Materias:
R
Q
Acceso en línea:https://doaj.org/article/be13d69a4f7349cfb9001a109c5fd7b5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:be13d69a4f7349cfb9001a109c5fd7b5
record_format dspace
spelling oai:doaj.org-article:be13d69a4f7349cfb9001a109c5fd7b52021-11-25T06:17:42ZIL-1beta, IL-6, and RANTES as biomarkers of Chikungunya severity.1932-620310.1371/journal.pone.0004261https://doaj.org/article/be13d69a4f7349cfb9001a109c5fd7b52009-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19156204/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Little is known about the immunopathogenesis of Chikungunya virus. Circulating levels of immune mediators and growth factors were analyzed from patients infected during the first Singaporean Chikungunya fever outbreak in early 2008 to establish biomarkers associated with infection and/or disease severity.<h4>Methods and findings</h4>Adult patients with laboratory-confirmed Chikungunya fever infection, who were referred to the Communicable Disease Centre/Tan Tock Seng Hospital during the period from January to February 2008, were included in this retrospective study. Plasma fractions were analyzed using a multiplex-microbead immunoassay. Among the patients, the most common clinical features were fever (100%), arthralgia (90%), rash (50%) and conjunctivitis (40%). Profiles of 30 cytokines, chemokines, and growth factors were able to discriminate the clinical forms of Chikungunya from healthy controls, with patients classified as non-severe and severe disease. Levels of 8 plasma cytokines and 4 growth factors were significantly elevated. Statistical analysis showed that an increase in IL-1beta, IL-6 and a decrease in RANTES were associated with disease severity.<h4>Conclusions</h4>This is the first comprehensive report on the production of cytokines, chemokines, and growth factors during acute Chikungunya virus infection. Using these biomarkers, we were able to distinguish between mild disease and more severe forms of Chikungunya fever, thus enabling the identification of patients with poor prognosis and monitoring of the disease.Lisa F P NgAngela ChowYong-Jiang SunDyan J C KwekPoh-Lian LimFrederico DimatatacLee-Ching NgEng-Eong OoiKhar-Heng ChooZhisheng HerPhilippe KourilskyYee-Sin LeoPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 4, Iss 1, p e4261 (2009)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Lisa F P Ng
Angela Chow
Yong-Jiang Sun
Dyan J C Kwek
Poh-Lian Lim
Frederico Dimatatac
Lee-Ching Ng
Eng-Eong Ooi
Khar-Heng Choo
Zhisheng Her
Philippe Kourilsky
Yee-Sin Leo
IL-1beta, IL-6, and RANTES as biomarkers of Chikungunya severity.
description <h4>Background</h4>Little is known about the immunopathogenesis of Chikungunya virus. Circulating levels of immune mediators and growth factors were analyzed from patients infected during the first Singaporean Chikungunya fever outbreak in early 2008 to establish biomarkers associated with infection and/or disease severity.<h4>Methods and findings</h4>Adult patients with laboratory-confirmed Chikungunya fever infection, who were referred to the Communicable Disease Centre/Tan Tock Seng Hospital during the period from January to February 2008, were included in this retrospective study. Plasma fractions were analyzed using a multiplex-microbead immunoassay. Among the patients, the most common clinical features were fever (100%), arthralgia (90%), rash (50%) and conjunctivitis (40%). Profiles of 30 cytokines, chemokines, and growth factors were able to discriminate the clinical forms of Chikungunya from healthy controls, with patients classified as non-severe and severe disease. Levels of 8 plasma cytokines and 4 growth factors were significantly elevated. Statistical analysis showed that an increase in IL-1beta, IL-6 and a decrease in RANTES were associated with disease severity.<h4>Conclusions</h4>This is the first comprehensive report on the production of cytokines, chemokines, and growth factors during acute Chikungunya virus infection. Using these biomarkers, we were able to distinguish between mild disease and more severe forms of Chikungunya fever, thus enabling the identification of patients with poor prognosis and monitoring of the disease.
format article
author Lisa F P Ng
Angela Chow
Yong-Jiang Sun
Dyan J C Kwek
Poh-Lian Lim
Frederico Dimatatac
Lee-Ching Ng
Eng-Eong Ooi
Khar-Heng Choo
Zhisheng Her
Philippe Kourilsky
Yee-Sin Leo
author_facet Lisa F P Ng
Angela Chow
Yong-Jiang Sun
Dyan J C Kwek
Poh-Lian Lim
Frederico Dimatatac
Lee-Ching Ng
Eng-Eong Ooi
Khar-Heng Choo
Zhisheng Her
Philippe Kourilsky
Yee-Sin Leo
author_sort Lisa F P Ng
title IL-1beta, IL-6, and RANTES as biomarkers of Chikungunya severity.
title_short IL-1beta, IL-6, and RANTES as biomarkers of Chikungunya severity.
title_full IL-1beta, IL-6, and RANTES as biomarkers of Chikungunya severity.
title_fullStr IL-1beta, IL-6, and RANTES as biomarkers of Chikungunya severity.
title_full_unstemmed IL-1beta, IL-6, and RANTES as biomarkers of Chikungunya severity.
title_sort il-1beta, il-6, and rantes as biomarkers of chikungunya severity.
publisher Public Library of Science (PLoS)
publishDate 2009
url https://doaj.org/article/be13d69a4f7349cfb9001a109c5fd7b5
work_keys_str_mv AT lisafpng il1betail6andrantesasbiomarkersofchikungunyaseverity
AT angelachow il1betail6andrantesasbiomarkersofchikungunyaseverity
AT yongjiangsun il1betail6andrantesasbiomarkersofchikungunyaseverity
AT dyanjckwek il1betail6andrantesasbiomarkersofchikungunyaseverity
AT pohlianlim il1betail6andrantesasbiomarkersofchikungunyaseverity
AT fredericodimatatac il1betail6andrantesasbiomarkersofchikungunyaseverity
AT leechingng il1betail6andrantesasbiomarkersofchikungunyaseverity
AT engeongooi il1betail6andrantesasbiomarkersofchikungunyaseverity
AT kharhengchoo il1betail6andrantesasbiomarkersofchikungunyaseverity
AT zhishengher il1betail6andrantesasbiomarkersofchikungunyaseverity
AT philippekourilsky il1betail6andrantesasbiomarkersofchikungunyaseverity
AT yeesinleo il1betail6andrantesasbiomarkersofchikungunyaseverity
_version_ 1718413949197615104